Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 known ✓ | P09917 | 3/20 | 0.60 |
| ▸ | NAAA | Q02083 | 2/20 | 0.67 |
| ▸ | HTT | P42858 | 3/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.58 |
| ▸ | HPGD | P15428 | 2/20 | 0.58 |
| ▸ | NPC1 | O15118 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.58 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.58 |
| ▸ | NAMPT | P43490 | 1/20 | 0.56 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | ESRRG | P62508 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Salcaprozic Acid SCHEMBL29509907 | 1.00 | NAAA (0.67) | NAAAALOX5HTTALDH1A1TSHR | |
| Salcaprozic Acid SCHEMBL825599 | 1.00 | NAAA (0.67) | NAAAALOX5HTTALDH1A1TSHR | |
| SCHEMBL253212 | 1.00 | NAAA (0.67) | NAAAALOX5HTTALDH1A1TSHR | |
| Salcaprozic Acid SCHEMBL20511604 | 1.00 | NAAA (0.67) | NAAAALOX5HTTALDH1A1TSHR | |
| Salcaprozic Acid SCHEMBL26908047 | 0.97 | NAAA (0.67) | NAAAALOX5HTTALDH1A1TSHR | |
| Alcohol SCHEMBL2331970 | 0.95 | NAAA (0.68) | NAAAALOX5HTTALDH1A1TSHR | |
| SCHEMBL4956771 | 0.94 | TSHR (0.61) | NAAAALOX5HTTALDH1A1TSHR | |
| Salcaprozic Acid SCHEMBL29036081 | 0.90 | NAAA (0.65) | NAAAALOX5HTTALDH1A1TSHR | |
| Salcaprozic Acid SCHEMBL29036010 | 0.90 | NAAA (0.65) | NAAAALOX5HTTALDH1A1TSHR | |
| SCHEMBL823552 | 0.87 | NAAA (0.84) | NAAAALOX5HTTALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8658695-B2 | Disodium salts, monohydrates, and ethanol solvates for delivering active agents | EMISPHERE TECHNOLOGIES, INC. (US) | 2014-02-25 | — | — | US | disclosed |
| US-20120264834-A1 | DISODIUM SALTS, MONOHYDRATES, AND ETHANOL SOLVATES FOR DELIVERING ACTIVE AGENTS | NOVARTIS AG (CH) | 2012-10-18 | — | — | US | disclosed |
| US-8207227-B2 | Disodium salts, monohydrates, and ethanol solvates for delivering active agents | EMISPHERE TECHNOLOGIES, INC. (US) | 2012-06-26 | — | — | US | disclosed |
| US-20110251125-A1 | DISODIUM SALTS, MONOHYDRATES, AND ETHANOL SOLVATES FOR DELIVERING ACTIVE AGENTS | NOVARTIS AG (CH) | 2011-10-13 | — | — | US | disclosed |
| US-8003697-B2 | Disodium salts, monohydrates, and ethanol solvates for delivering active agents | EMISPHERE TECHNOLOGIES, INC. (US) | 2011-08-23 | — | — | US | disclosed |
| US-20100099621-A1 | DISODIUM SALTS, MONOHYDRATES, AND ETHANOL SOLVATES FOR DELIVERING ACTIVE AGENTS | EMISPHERE TECHNOLOGIES, INC. (US) | 2010-04-22 | — | — | US | disclosed |
| US-7659311-B2 | Disodium salts, monohydrates, and ethanol solvates for delivering active agents | NOVARTIS AG (CH) | 2010-02-09 | — | — | US | disclosed |
| US-20080269134-A1 | DISODIUM SALTS, MONOHYDRATES, AND ETHANOL SOLVATES FOR DELIVERING ACTIVE AGENTS | EMISPHERE TECHNOLOGIES, INC. (US) | 2008-10-30 | — | — | US | disclosed |
| US-7384982-B2 | Disodium salts, monohydrates, and ethanol solvates for delivering active agents | EMISPHERE TECHNOLOGIES, INC. (US) | 2008-06-10 | — | — | US | disclosed |
| EP-1535625-A1 | Composition containing n-(5-chlorosalicyloyl)-8-aminocaprylic acid and salmon calcitonin | Emisphere Technologies, Inc. (US) | 2005-06-01 | — | — | EP | disclosed |
| EP-1175390-B1 | DISODIUM SALTS, MONOHYDRATES, AND ETHANOL SOLVATES | EMISPHERE TECH INC (US) | 2005-02-02 | — | — | EP | disclosed |
| US-20040106825-A1 | Disodium salts, monohydrates, and ethanol solvates for delivering active agents | EMISPHERE TECHNOLOGIES, INC. | 2004-06-03 | — | — | US | disclosed |
| EP-1175390-A4 | DISODIUM SALTS, MONOHYDRATES, AND ETHANOL SOLVATES | EMISPHERE TECH INC (US) | 2002-09-04 | — | — | EP | disclosed |
| US-20020065255-A1 | Disodium salts, monohydrates, and ethanol solvates for delivering active agents | EMISPHERE TECHNOLOGIES, INC. (US) | 2002-05-30 | — | — | US | disclosed |
| EP-1175390-A1 | DISODIUM SALTS, MONOHYDRATES, AND ETHANOL SOLVATES | Emisphere Technologies, Inc. (US) | 2002-01-30 | — | — | EP | disclosed |
| WO-2000059863-A1 | DISODIUM SALTS, MONOHYDRATES, AND ETHANOL SOLVATES | EMISPHERE TECHNOLOGIES, INC. (US) | 2000-10-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020065255-A1 | Disodium salts, monohydrates, and ethanol solvates for delivering active agents | ADH1C, CLIC1, SLC9A1 | ALOX5 2176/4885NAAA 256/4885HTT 682/4885 |
| US-20110251125-A1 | DISODIUM SALTS, MONOHYDRATES, AND ETHANOL SOLVATES FOR DELIVERING ACTIVE AGENTS | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, ADH1C, HCAR3 | ALOX5 1194/4885NAAA 141/4885HTT 357/4885 |
| US-20080269134-A1 | DISODIUM SALTS, MONOHYDRATES, AND ETHANOL SOLVATES FOR DELIVERING ACTIVE AGENTS | HCAR3, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, ADH1C | ALOX5 1086/4885NAAA 133/4885HTT 403/4885 |
| US-20120264834-A1 | DISODIUM SALTS, MONOHYDRATES, AND ETHANOL SOLVATES FOR DELIVERING ACTIVE AGENTS | ACMSD, SLC38A7, SLC10A1 | ALOX5 1074/4885NAAA 111/4885HTT 414/4885 |
| US-20100099621-A1 | DISODIUM SALTS, MONOHYDRATES, AND ETHANOL SOLVATES FOR DELIVERING ACTIVE AGENTS | HCAR3, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, ADH1C | ALOX5 1086/4885NAAA 133/4885HTT 403/4885 |
| US-20040106825-A1 | Disodium salts, monohydrates, and ethanol solvates for delivering active agents | ADH1C, CLIC1, SLC9A1 | ALOX5 2176/4885NAAA 256/4885HTT 682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.